The following clinical trials are associated with All diseases and conditions.
- collapse Study to Assess the Pharmacokinetics of Pioglitazone in Healthy Subjects when Administered Alone and in Combination with Fostamatinib 100 mg Twice Daily
- collapse Non-interventional study to observe efficacy and usage of quetiapine in acute episodes of schizophrenia and as maintenance therapy following standard clinical practice in Croatia
- collapse Phase I, open label, healthy volunteers, ADME study with single oral administration of [14C] AZD8931
- collapse Effects of administration of fostamatinib on blood concentrations of an oral contraceptive in healthy female subjects.
- collapse An Open-Label, Single Centre Study to Assess the Pharmacokinetics and Pharmacodynamics of Warfarin when Co-Administered with Fostamatinib in Healthy Subjects
- collapse Open-Labelled, Single Arm, Phase IV Clinical Study to Evaluate the Impact of Rosuvastatin on Lipid Levels in Patients With Metabolic Syndrome (EFFORT)
- collapse Assessment of the Safety, Tolerability and Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules.
- collapse Non-interventional observational study to evaluate change of PSA levels in patients with advanced prostate cancer treated with bicalutamide in combination with medical or surgical castration
- collapse Prevalence of osteoporosis in Korean prostate cancer patients who is reciving LHRH agonist and/or anti-androgen agent
- collapse (OSKIRA-4): A Phase IIB, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Fostamatinib Disodium Monotherapy Compared With Adalimumab Monotherapy in Patients With Active Rheumatoid Arthritis
